Annual Current Ratio
0.66
-0.73-52.52%
30 September 2023
Summary:
Outlook Therapeutics annual current ratio is currently 0.66, with the most recent change of -0.73 (-52.52%) on 30 September 2023. During the last 3 years, it has fallen by -2.53 (-79.31%). OTLK annual current ratio is now -79.31% below its all-time high of 3.19, reached on 30 September 2021.OTLK Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Ratio
1.07
0.000.00%
30 June 2024
Summary:
Outlook Therapeutics quarterly current ratio is currently 1.07, unchanged on 30 June 2024. Over the past year, it has increased by +0.41 (+62.12%). OTLK quarterly current ratio is now -73.84% below its all-time high of 4.09, reached on 31 December 2022.OTLK Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OTLK Current Ratio Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | +62.1% |
3 y3 years | -79.3% | -66.5% |
5 y5 years | -1.5% | +59.7% |
OTLK Current Ratio High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -79.3% | at low | -73.8% | +143.2% |
5 y | 5 years | -79.3% | at low | -73.8% | +224.2% |
alltime | all time | -79.3% | +560.0% | -73.8% | +5250.0% |
Outlook Therapeutics Current Ratio History
Date | Annual | Quarterly |
---|---|---|
June 2024 | - | 1.07(0.0%) |
Mar 2024 | - | 1.07(+143.2%) |
Dec 2023 | - | 0.44(-33.3%) |
Sept 2023 | 0.66(-52.5%) | 0.66(-23.3%) |
June 2023 | - | 0.86(-29.5%) |
Mar 2023 | - | 1.22(-70.2%) |
Dec 2022 | - | 4.09(+194.2%) |
Sept 2022 | 1.39(-56.4%) | 1.39(-31.9%) |
June 2022 | - | 2.04(-3.8%) |
Mar 2022 | - | 2.12(-45.4%) |
Dec 2021 | - | 3.88(+21.6%) |
Sept 2021 | 3.19(+182.3%) | 3.19(+96.9%) |
June 2021 | - | 1.62(-11.5%) |
Mar 2021 | - | 1.83(+101.1%) |
Dec 2020 | - | 0.91(-19.5%) |
Sept 2020 | 1.13 | 1.13(-26.1%) |
June 2020 | - | 1.53(+282.5%) |
Mar 2020 | - | 0.40(+21.2%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2019 | - | 0.33(-50.7%) |
Sept 2019 | 0.67(+570.0%) | 0.67(-17.3%) |
June 2019 | - | 0.81(+912.5%) |
Mar 2019 | - | 0.08(0.0%) |
Dec 2018 | - | 0.08(-20.0%) |
Sept 2018 | 0.10(-28.6%) | 0.10(-75.6%) |
June 2018 | - | 0.41(+86.4%) |
Mar 2018 | - | 0.22(-55.1%) |
Dec 2017 | - | 0.49(+250.0%) |
Sept 2017 | 0.14(-50.0%) | 0.14(+366.7%) |
June 2017 | - | 0.03(+50.0%) |
Mar 2017 | - | 0.02(-80.0%) |
Dec 2016 | - | 0.10(-64.3%) |
Sept 2016 | 0.28(-31.7%) | 0.28(-56.9%) |
June 2016 | - | 0.65(+490.9%) |
Mar 2016 | - | 0.11(-70.3%) |
Dec 2015 | - | 0.37(-9.8%) |
Sept 2015 | 0.41(0.0%) | 0.41 |
Sept 2014 | 0.41 | - |
FAQ
- What is Outlook Therapeutics annual current ratio?
- What is the all time high annual current ratio for Outlook Therapeutics?
- What is Outlook Therapeutics quarterly current ratio?
- What is the all time high quarterly current ratio for Outlook Therapeutics?
- What is Outlook Therapeutics quarterly current ratio year-on-year change?
What is Outlook Therapeutics annual current ratio?
The current annual current ratio of OTLK is 0.66
What is the all time high annual current ratio for Outlook Therapeutics?
Outlook Therapeutics all-time high annual current ratio is 3.19
What is Outlook Therapeutics quarterly current ratio?
The current quarterly current ratio of OTLK is 1.07
What is the all time high quarterly current ratio for Outlook Therapeutics?
Outlook Therapeutics all-time high quarterly current ratio is 4.09
What is Outlook Therapeutics quarterly current ratio year-on-year change?
Over the past year, OTLK quarterly current ratio has changed by +0.41 (+62.12%)